Racklipedia
Racklify
​
Manufacturing

What Is FDA Drug Establishment Registration? Requirements And Process

Updated October 19, 2026
Published October 19, 2026

FDA Drug Establishment Registration

Definition

FDA registration for covered establishments engaged in manufacturing, repacking, relabeling, or salvaging drugs for U.S. distribution.

Overview

FDA Drug Establishment Registration FDA registration for covered establishments engaged in manufacturing, repacking, relabeling, or salvaging drugs for U.S. distribution. This registration is a statutory and regulatory requirement that identifies facilities the FDA can inspect, ties a facility to its drug products, and supports product tracing, compliance, and safety oversight.


Registration is distinct from product listing: establishments register as places that perform covered operations, and registrants must also list the drug products associated with those facilities. The regulatory basis and operational details are set out in 21 CFR Part 207 and FDA guidance and systems that capture establishment and listing information electronically.


Who Must Register


Covered activities generally include manufacturing, preparation, propagation, compounding, processing, repacking, relabeling, or salvaging of drug products intended for U.S. distribution. That covers contract manufacturers and repackers, in-house production lines at brand owners, and salvagers who restore adulterated or misbranded products for distribution. Certain entities are excluded or exempt under specific conditions (for example, some retail pharmacy activities and some compounded preparations under applicable statutes), so facilities should confirm applicability for each operation.


What The Registration Typically Covers


  • Facility Identity: Legal business name, physical address, and contact details submitted to FDA systems.
  • Activities Performed: Specific covered operations such as manufacturing, repacking, relabeling, or salvaging.
  • Owner/Operator: The person or firm legally responsible for the establishment.
  • U.S. Agent (for Foreign Establishments): A designated U.S.-based contact for FDA communications when the facility is located outside the United States.


How To Register (High-Level Steps)


Registration today is completed electronically via FDA systems. Practical steps typically include:


  • Prepare Information: Gather facility legal name, physical address, owner/operator details, and descriptions of covered operations.
  • Access FDA Portal: Use FDA’s registration and listing system (FDA’s online registration tools) to create an account if needed.
  • Submit Registration: Complete the establishment registration form and submit; the FDA assigns an FEI (Facility Establishment Identifier) on acceptance.
  • List Products: After registration, list any drug products associated with the establishment per the drug listing process.


When To Update And Renew


Registration information must remain current. Changes to ownership, facility address, or the types of operations performed require prompt updates through FDA’s system. Additionally, establishments must register annually. The specific renewal window and timing are defined by regulation and FDA procedures; failing to renew or to update material changes can expose an establishment to enforcement actions or import refusals for foreign facilities.


Enforcement And Practical Consequences


Failure to register, to list products properly, or to maintain accurate registration can bring administrative and regulatory consequences. For domestic facilities, noncompliance may lead to warning letters, injunctions, or seizure actions if product safety issues arise. Foreign establishments risk import detention or refusal of entry until registration deficiencies are corrected. Registration also subjects a facility to inspection and record requests under FDA authority.


Practical Example


A contract manufacturer in North Carolina that repacks sterile injectables for multiple brand owners must register its facility with the FDA, list each client’s products produced at the site, and update the registration if it adds relabeling services. If the same company opens a satellite repacking line in Mexico, the Mexican facility must register as a foreign establishment and designate a U.S. agent for FDA communications.


Tips For Warehouse, Manufacturing, And 3PL Operators


  • Inventory Your Activities: Map each warehouse and production location to the covered operations it performs (manufacture, repack, relabel, salvage).
  • Assign Responsibility: Identify who in your organization will own registration maintenance and FDA communications.
  • Integrate With QMS: Link registration records to quality and compliance systems so updates trigger reviews and submissions.
  • Use Accurate Addresses: Provide physical site locations (not P.O. boxes) to avoid processing delays.


In short, the FDA Drug Establishment Registration is the formal registration obligation for facilities involved in manufacturing, repacking, relabeling, or salvaging drugs for U.S. distribution; it is an administrative anchor for product listing, inspection readiness, and regulatory oversight and must be kept accurate and current as operations change.


Sources And Additional Reading (3)

More from this term
Looking for a 3PL?

Compare warehouses on Racklify and find the right logistics partner for your business.